by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
ALAMEDA, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, today reported its financial results for the second quarter ended June 30, 2016 along with...
by GlobeNewsWire | Aug 10, 2016 | Globe Newswire
– Recent Positive Dose Titration Data from Pivotal Phase 3 Clinical Program — On Track for New Drug Application Submission in the First Half of 2017 – TORONTO, Aug. 10, 2016 (GLOBE NEWSWIRE) — Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH),...
by GlobeNewsWire | Aug 10, 2016 | Globe Newswire
Minneapolis, Aug. 10, 2016 (GLOBE NEWSWIRE) — For Immediate Release: PetVivo Names Gary DeMel, Executive Vice President of Business Development MINNEAPOLIS, MN August 10, 2016 PetVivo Holdings, Inc. (OTCPINK:PETV) an emerging biomedical device company focused on...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
NORTHVALE, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (NASDAQ:CHRS), today announced submission of the biologics license application (BLA) for CHS-1701, a pegfilgrastim (Neulasta®) biosimilar candidate, to U.S. FDA under the 351(k)...